Net income increased 142.0%
Net income changed +142.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +142.0% from the comparable as-filed period.
Operating income changed +67.2% from the comparable as-filed period.
Research & development changed +23.9% from the comparable as-filed period.
Stock-based compensation changed +16.6% from the comparable as-filed period.
Cash & equivalents changed -14.3% from the comparable as-filed period.
Operating margin changed +279 basis points from the comparable as-filed period.
Gross margin changed +174 basis points from the comparable as-filed period.
Gross profit changed +11.2% from the comparable as-filed period.
Revenue changed +8.6% from the comparable as-filed period.
Inventory changed -1.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.